期刊文献+

前列腺中央腺体MR波谱谱线的信噪比研究 被引量:2

Signal-noise ratio of MR spectroscopy in the central gland of prostate
原文传递
导出
摘要 目的了解前列腺中央腺体 MR 波谱(MRS)谱线的信噪比(sNR)与病变性质的关系。方法对18例因良性前列腺增生(BPH)行经尿道前列腺切除(TURP)术患者的 MRS 谱线作回顾性分析。根据病理结果分为3组:中央腺体偶发癌(IDPC)组5例、腺体增生为主的 BPH(glandularBPH,GBPH)组7例和基质增生为主的 BPH(stromal BPH,SBPH)组6例。统计中央腺体感兴趣区内所有SNR≥5、SNR<5和有脂峰干扰的体素数量及所占比率情况,分析 SNR 与病变性质的关系。结果 18例患者共测量体素3632个,SNR≥5体素1579个(占总测量体素的43%),SNR<5的体素1873个。SBPH 组 SNR<5的体素所占比率(67.6±21.8)%大于 GBPH 组(37.1±14.5)%和 IDPC组(39.9±18.8)%,差异有统计学意义(P<0.05);GBPH 组和 IDPC 组比较,差异无统计学意义(P>0.05)。结论前列腺中央腺体的 MRS 谱线中,部分谱线由于 SNR 低,不能用于代谢物半定量分析,尤以 SBPH 患者的 SNR<5体素所占比率最大。 Objective To analyze the signal to noise ratio (SNR) of the MRS of the prostate central gland, and study its relationship with the pathology of the lesions. Methods Eighteen patients who underwent transurethral resection of prostate (TURP) for benign prostate hyperplasia (BPH) were enrolled in this study. They were divided into three groups according to the pathological findings: 7 cases of glandular-BPH (GBPH), 7 cases of stromal-BPH (SBPH) and 5 cases of incidentally detected prostate carcinoma (IDPC). The voxels in the central glands with SNR ≥ 5 and SNR 〈 5 were counted, and the relationship between the percentage of voxel with SNR 〈 5 and pathology was analyzed. Results In the 18 cases, the total number of voxels measured in the regions of interest was 3632, and the voxels with SNR≥5 and SNR 〈 5 were 1579 (the percentage is 43% ) and 1873, respectively. The percentage of voxels with SNR 〈5 in SBPH group (67. 6 ± 21.8) % was statistically higher than that in GBPH (37.1 ± 14. 5) % and IDPC (39. 9 ± 18. 8) %. The difference between the group of GBPH and IDPC was not statistically significant. Conclusion More than half of the voxels in the central gland could not be reliably analyzed in the prostate MRS examination because of its low SNR, especially in the case of SBPH.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2007年第11期1213-1216,共4页 Chinese Journal of Radiology
关键词 良性前列腺增生 前列腺癌 磁共振波谱学 Prostatic hyperplasia Prostatic neoplasms Magnetic resonance spectroscopy
  • 相关文献

参考文献10

  • 1周良平,王霄英,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.正常前列腺、前列腺癌和良性前列腺增生的MR波谱成像代谢特征并与病理结果对照[J].中华放射学杂志,2005,39(1):50-53. 被引量:34
  • 2Bovee WM, Keevil SF, Leach MO, et al. Quality assessment in vivo NMR spectroscopy:Ⅱ. A protocol for quality assessment. EEC Concerted Research Project. Magn Reson Imaging,1995,13: 123 -129.
  • 3王霄英,周良平,蒋学祥.前列腺三维磁共振波谱成像的初步研究[J].中国医学影像技术,2002,18(11):1154-1157. 被引量:35
  • 4Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR imaging of the in situ human prostate with high( 0.24-0.7cm^3 ) spatial resolution. Radiology, 1996,198: 795 -805.
  • 5Kaji Y, Kurhanewiez J, Hricak H, et al. Localizing prostate cancer in the presence of postbiopsy changes on MR images : role of proton MR spectroscopic imaging. Radiology, 1998, 206: 785-790.
  • 6Zakian KL, Eberhardt S, Hricak H, et al. Transition zone prostate cancer:metabolic characteristics at 1H MR spectroscopic imaging-initial results. Radiology ,2003,229:241-247.
  • 7李飞宇,王霄英,丁建平,周良平,黄嵘,蒋学祥.中国男性良性前列腺增生的MR波谱定量分析[J].中华放射学杂志,2005,39(4):390-393. 被引量:18
  • 8Lowry M, Liney GP, Turnbull LW, et al. Quantification of citrate concentration in the prostate by proton magnetic spectroscopy: zonal and age-related differences. Magn Reson Med,1996,36: 352-358.
  • 9Ackerstaff E, Pflug BR, Nelson SJ, et aL Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent transformation of prostatic epithelial cells. Cancer Research,2001,61:3599-3603.
  • 10王霄英,周良平,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.RS对中国人前列腺癌鉴别诊断标准的初步研究[J].中国医学影像技术,2004,20(8):1150-1153. 被引量:98

二级参考文献27

  • 1王霄英,周良平,丁建平,王刚,肖江喜,蒋学祥.中国正常成年男性前列腺的MRS定量分析[J].中国医学影像技术,2003,19(5):576-578. 被引量:24
  • 2王继琛,高玉洁,蒋学祥,李松年,刘赓年.前列腺癌的MRI诊断与分期[J].中华放射学杂志,1996,30(11):741-744. 被引量:28
  • 3[1]Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR imaging of the in situ human prostate with high (0.24-0.7 cm3) spatial resolution[J]. Radiology, 1996, 198(3): 795-805.
  • 4[2]Cornud F, Flam T, Chauveinc, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results[J]. Radiology, 2002, 224(1): 203-210.
  • 5[5]Bartolozzi C, Crocetti L, Menchi I, et al. Endorectal magnetic resonance imaging in local staging of prostate carcinoma[J]. Abdom Imaging, 2001, 26(2): 111-122.
  • 6[6]Lowry M, Liney GP, Turnbull LW, et al. Quantification of citrate concentration in the prostate by proton magnetic spectroscopy: zonal and age-related differences[J]. Magn Reson Med, 1996, 36(3): 252-358.
  • 7[7]Kurhanewicz J, Swanson MG, Wood PJ, et al. Magnetic resonance imaging and spectroscopic imaging: improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials[J]. Urology, 2001, 57(suppl 4A): 124-128.
  • 8[8]Hahn P, Smith ICP, Leboldus L, et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra[J]. Cancer Research, 1997, 57(6): 3398-3401.
  • 9[9]Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings[J]. Radiology, 1989, 172(1): 131-137.
  • 10[10]Muramoto S, Uematsu H, Kimura H, et al. Differential of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging[J]. Euro J Radio, 2002, 44(1): 52-58.

共引文献144

同被引文献21

  • 1张凯,李传福,刘影,丛培新,郑金勇,冯德朝,孟祥水.对比剂对3 T氢质子MR波谱的影响[J].中华放射学杂志,2006,40(10):1095-1097. 被引量:5
  • 2Smith JK, Kwock L, Castillo M, Effects of contrast material on single- volume proton MR spectroscopy. AJNR, 2000, 21: 1084- 1089.
  • 3Wang L, Mazaheri Y, Zhang J, et al. Assessment of biologic aggres- siveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy[ J]. Radiology ,2008,246 : 168-176.
  • 4Wang L, Zhang J, Schwartz LH, et al. Incremental value of muhipla- nar cross-referencing for prostate cancer staging with endorectal MRI [ J]. AJR,2007,188:99-104.
  • 5CuUu N,Kantarci M, Ogul H,et al. Feasibility study of CT perfusion imaging for prostate carcinoma [ J ]. Eur Radiol, 2014, 24 : 2236- 2244.
  • 6Johnson LM, Turkbey B, Figg WD, et al. Muhiparametric MRI in prostate cancer management [ J]. Nat Rev Clin Oncol,2014,11 : 346- 353.
  • 7Kerbel RS . Tumor angiogenesis [ J ]. N Engl J Med, 2008,358: 2039 -2049.
  • 8Li C, Chen M, Li S, et al. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dy- namic contrast-enhanced MRI, and the two techniques combined at 3.0 T[ J ]. Aeta Radiol,2014,55:239-247.
  • 9梁长虹,徐莉,刘再毅,崔燕海,刘春玲,郑君惠,曾琼新.在体肝脏3.0T^1H—MR波谱匀场及抑水影响因素探讨[J].中华放射学杂志,2009,43(7):739-742. 被引量:12
  • 10杨春,路欣,程丽,张秀莉,荣玉涛,徐凯,郑骏年.SPIO与Gd-DTPA增强对裸鼠肾癌移植瘤显影价值对照研究[J].中国医学计算机成像杂志,2009,15(6):542-545. 被引量:2

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部